Agenus to Present at the JMP Securities Annual Healthcare Conference
LEXINGTON, Mass., July 2, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN),
a developer of therapeutic vaccines for cancer and infectious diseases, today
announced that the company will be presenting at the JMP Securities 8^th
Annual Healthcare Conference, which will be held at the St. Regis New York.
Dr. Garo Armen, Chairman and CEO of Agenus, will present a corporate overview
on Tuesday, July 9^th at 12:30 pm ET.
Web Cast Information
The live and archived webcast of the company presentation will be accessible
from the company's website at www.agenusbio.com/webcast. Please log in
approximately 5-10 minutes before each event to ensure a timely connection.
The archived replay will be available on the Agenus website for one month
following the conference.
Agenus Inc. is a biotechnology company working to develop treatments for
cancers and infectious diseases. The company is focused on immunotherapeutic
products based on strong platform technologies with multiple product
candidates advancing through the clinic, including several product candidates
that have advanced into late-stage clinical trials through corporate partners.
For more information, please visit www.agenusbio.com.
CONTACT: Media and Investor Contact:
Jonae R. Barnes
Investor Relations and
Press spacebar to pause and continue. Press esc to stop.